• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗惊厥药D,L-3-羟基-3-乙基-3-苯基丙酰胺的血浆测定及大鼠体内初步药代动力学研究

Plasma determination of the novel anticonvulsant D,L-3-hydroxy-3-ethyl-3-phenylpropionamide and preliminary pharmacokinetic studies in the rat.

作者信息

Gomez L E, Lehmann P A

机构信息

Departamento de Farmacología y Toxicología, Centro de Investigación y de Estudios Avanzados, Instituto Politécnico Nacional, Mexico City, Mexico.

出版信息

J Chromatogr. 1992 Mar 27;575(2):306-10. doi: 10.1016/0378-4347(92)80162-j.

DOI:10.1016/0378-4347(92)80162-j
PMID:1629310
Abstract

A sensitive gas chromatographic method with flame ionization detection was developed for the analysis in plasma of the novel anticonvulsant D,L-3-hydroxy-3-ethyl-3-phenylpropionamide (HEPP), using D,L-2-hydroxy-2-ethyl-2-phenylacetamide as the internal standard. HEPP was extracted from alkalinized plasma into dichloromethane and quantified after derivatization with bis(trimethylsilyl)-trifluoroacetamide: Standard curves were linear from 0.5 to 50 and from 2 to 100 micrograms/ml of plasma, using 1.5 and 5 micrograms of the internal standard, respectively. The lower limit of detection at a signal-to-noise ratio of 3 standard deviations was 0.33 micrograms/ml of sample. The sensitivity, accuracy and reproducibility of the method were shown to be satisfactory for pharmacokinetic studies of HEPP. After intraperitoneal administration of 50 mg/kg to Wistar rats, the principal kinetic parameters were: absorption half-life = 0.04 h; volume of distribution = 1.32 l/kg; clearance = 4.40 ml/min; peak concentration = 50 micrograms/ml; peak time = 0.25 h; mean residence time = 4.55 h.

摘要

建立了一种采用火焰离子化检测的灵敏气相色谱法,以D,L-2-羟基-2-乙基-2-苯基乙酰胺为内标,用于分析新型抗惊厥药D,L-3-羟基-3-乙基-3-苯基丙酰胺(HEPP)在血浆中的含量。HEPP从碱化血浆中萃取至二氯甲烷中,并用双(三甲基硅基)-三氟乙酰胺进行衍生化后定量:分别使用1.5微克和5微克内标时,标准曲线在血浆浓度为0.5至50微克/毫升以及2至100微克/毫升范围内呈线性。在信噪比为3倍标准差时,检测下限为0.33微克/毫升样品。该方法的灵敏度、准确度和重现性对于HEPP的药代动力学研究而言令人满意。给Wistar大鼠腹腔注射50毫克/千克后,主要动力学参数为:吸收半衰期=0.04小时;分布容积=1.32升/千克;清除率=4.40毫升/分钟;峰浓度=50微克/毫升;达峰时间=0.25小时;平均驻留时间=4.55小时。

相似文献

1
Plasma determination of the novel anticonvulsant D,L-3-hydroxy-3-ethyl-3-phenylpropionamide and preliminary pharmacokinetic studies in the rat.新型抗惊厥药D,L-3-羟基-3-乙基-3-苯基丙酰胺的血浆测定及大鼠体内初步药代动力学研究
J Chromatogr. 1992 Mar 27;575(2):306-10. doi: 10.1016/0378-4347(92)80162-j.
2
Gestational age dependency in the prenatal toxicity and in the disposition kinetics of the novel anticonvulsant HEPP (D,L-3-hydroxy-3-ethyl-3-phenylpropionamide) after subcutaneous administration in pregnant rats.
Int J Toxicol. 2007 May-Jun;26(3):237-46. doi: 10.1080/10915810701352846.
3
Pharmacokinetics of the novel anticonvulsant HEPP after single intravenous administration of three different doses in dogs.
Biopharm Drug Dispos. 1995 Mar;16(2):105-12. doi: 10.1002/bdd.2510160205.
4
Disposition kinetics of HEPP in rats after intravenous, oral, and intraperitoneal administration. Correlation of plasma and brain levels with the anticonvulsant effect.
Biopharm Drug Dispos. 1995 Mar;16(2):77-89. doi: 10.1002/bdd.2510160203.
5
Single dose pharmacokinetics of HEPP, a new anticonvulsant in normal healthy volunteers.新型抗惊厥药HEPP在正常健康志愿者中的单剂量药代动力学
Biopharm Drug Dispos. 1998 Dec;19(9):583-7. doi: 10.1002/(sici)1099-081x(199812)19:9<583::aid-bdd139>3.0.co;2-y.
6
Pharmacokinetics of HEPP, a new anticonvulsant, in healthy subjects and rabbits after multiple doses.新型抗惊厥药物HEPP在健康受试者和家兔多次给药后的药代动力学
Biopharm Drug Dispos. 2004 Mar;25(2):85-90. doi: 10.1002/bdd.387.
7
Pharmacokinetic interaction in rabbits between a new anticonvulsant, DL-3-hydroxy-3-ethyl-3-phenylpropionamide, and phenytoin.新型抗惊厥药DL-3-羟基-3-乙基-3-苯基丙酰胺与苯妥英在兔体内的药代动力学相互作用。
J Pharm Pharmacol. 1998 Dec;50(12):1393-6. doi: 10.1111/j.2042-7158.1998.tb03365.x.
8
Pharmacokinetics of D,L-3-hydroxy-3-ethyl-3-phenylpropionamide (HEPP) in pregnant rats at different stages of gestation and maternal-fetal disposition during late pregnancy.妊娠不同阶段的孕鼠体内D,L-3-羟基-3-乙基-3-苯基丙酰胺(HEPP)的药代动力学及妊娠晚期的母胎分布情况
Reprod Toxicol. 2003 Mar-Apr;17(2):177-84. doi: 10.1016/s0890-6238(02)00129-6.
9
Liquid chromatographic assay in plasma of one of the members of a new series of anticonvulsants: D,L-3-hydroxy-3-ethyl-3-phenylpropionamide.新型抗惊厥药系列之一的D,L-3-羟基-3-乙基-3-苯基丙酰胺在血浆中的液相色谱测定法
J Chromatogr B Biomed Appl. 1996 Apr 12;678(2):377-83. doi: 10.1016/0378-4347(95)00554-4.
10
Lack of interaction between HEPP, a new antiepileptic agent, and carbamazepine in rabbits.新型抗癫痫药物HEPP与卡马西平在兔体内无相互作用。
Biopharm Drug Dispos. 2003 Jul;24(5):205-9. doi: 10.1002/bdd.356.